Topical application of neuronal nitric oxide synthase inhibitor accelerates cutaneous barrier recovery and prevents epidermal hyperplasia induced by barrier disruption

Journal of Investigative Dermatology

Volumn 127, Issue 7, 2007, Pages 1713-1719

  Ikeyama, Kazuyuki ^a   Fuziwara, Shigeyoshi ^a   Denda, Mitsuhiro ^a  

^a SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GUANYLATE CYCLASE ACTIVATOR; GUANYLATE CYCLASE INHIBITOR; METHYLISOTHIOUREA; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE INHIBITOR; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG INHIBITION; EPIDERMIS HYPERPLASIA; HAIRLESS MOUSE; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CULTURE; STATISTICAL ANALYSIS; WILD TYPE;

ADMINISTRATION, TOPICAL; ANIMALS; CALCIUM; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ENZYME INHIBITORS; HOMEOSTASIS; HUMANS; HYPERPLASIA; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED HRS; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; OXADIAZOLES; PENICILLAMINE; QUINOXALINES; SKIN;

EID: 34250663047     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700742     Document Type: Article

References (34)

1. Aoyama Y, Seishima M, Mori S, Kitajima Y, Okano Y, Nozawa Y (1995) Involvement of protein kinase C in bradykinin-induced intracellular calcium increase in primary cultured human keratinocytes. J Dermatol Sci 9:111-6
2. Ashida Y, Denda M, Hirao T (2001) Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Invest Dermatol 116:261-5
3. Biro T, Szabo I, Kovacs L, Hunyadi J, Csernoch L (1998) Distinct subpopulations in HaCaT cells as revealed by the characteristics of intracellular calcium release induced by phosphoinositide-coupled agonists. Arch Dermatol Res 290:270-6
4. Boissel JP, Ohly D, Bros M, Godtel-Armbrust U, Forstermann U, Frank S (2004) The neuronal nitric oxide synthase is upregulated in mouse skin repair and in response to epidermal growth factor in human HaCaT keratinocytes. J Invest Dermatol 123:132-9
5. Bredt DS, Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86:9030-3
6. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V (1998) Nitric oxide in human skin: current status and future prospects. J Invest Dermatol 110:1-7
7. Cals-Grierson MM, Ormerod AD (2004) Nitric oxide function in the skin. Nitric Oxide 10:179-93
8. 2+ homeostasis. Biochem Pharmacol 55:713-8
9. Denda M, Tsuchiya T (2000) Barrier recovery rate varies time-dependently in human skin. Br J Dermatol 142:881-4
10. Denda M, Sato J, Tsuchiya T, Elias PM, Feingold KR (1998) Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol 111:873-8
11. Denda M, Kitamura K, Elias PM, Feingold KR (1997) Trans-4-(aminomethyl)- cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J Invest Dermatol 109:84-90
12. Denda M, Fuziwara S, Inoue K (2003) Influx of calcium and chloride ions into epidermal keratinocytes regulates exocytosis of epidermal lamellar bodies and skin permeability barrier homeostasis. J Invest Dermatol 121:362-7
13. Elias PM, Feingold KR (2001) Coordinate regulation of epidermal differentiation and barrier homeostasis. Skin Pharmacol Appl Skin Physiol 14:28-34
14. Elias PM (2005) Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125:183-200
15. Gallala H, Macheleidt O, Doering T, Schreiner, Sandhoff K (2004) Nitric oxide regulates synthesis of gene products involved in keratinocyte differentiation and ceramide metabolism. Eur J Cell Biol 83:667-79
16. Giustizieri ML, Albanesi C, Scarponi C, De Pita O, Girolomoni G (2002) Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo. Am J Pathol 161:1409-18
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 269:3440-50
18. Hirooka K, Kourennyi DE, Barnes S (2000) Calcium channel activation facilitated by nitric oxide in retinal ganglion cells. J Neurophysiol 83:198-206
19. Horn TF, Wolf G, Duffy S, Weiss S, Keilhoff G, MacVicar BA (2002) Nitric oxide promotes intracellular calcium release from mitochondria in striatal neurons. FASEB J 16:1611-22
20. Jiang JL, Yu MK, Chen ZN, Chan HC (2001) cGMP-regulated store-operated calcium entry in human hepatoma cells. Cell Biol Int 25:993-5
21. Kaur K, Yao J, Pan X, Matthews C, Hassid A (1998) NO decreases phosphorylation of focal adhesion proteins via reduction of Ca in rat aortic smooth muscle cells. Am J Physiol 274(Part 2):H1613-9
22. Koizumi S, Uneyama H, Ikeda M, Ueno S, Inoue K (1998) Inhibition by imipramine of ATP-evoked responses in rat pheochromocytoma cells. Biochem Biophys Res Commun 244:342-6
23. Lau KS, Grange RW, Isotani E, Sarelius IH, Kamm KE, Huang PL, Stull JT (2000) nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle. Physiol Genomics 2:21-7
24. Lee SH, Elias PM, Proksch E, Menon GK, Mao-Quiang M, Feingold KR (1992) Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest 89:530-8
25. Ormerod AD, Weller R, Copeland P, Benjamin N, Ralston SH, Grabowksi P et al. (1998) Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res 290:3-8
26. Proksch E, Feingold KR, Man MQ, Elias PM (1991) Barrier function regulates epidermal DNA synthesis. J Clin Invest 87:1668-73
27. Romero-Graillet C, Aberdam E, Clement M, Ortonne JP, Ballotti R (1997) Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest 99:635-42
28. Rosenbach T, Liesegang C, Binting S, Czarnetzki BM (1993) Inositol phosphate formation and release of intracellular free calcium by bradykinin in HaCaT keratinocytes. Arch Dermatol Res 285:393-6
29. Rossi A, Catani MV, Candi E, Bernassola F, Puddu P, Melino G (2000) Nitric oxide inhibits cornified envelope formation in human keratinocytes by inactivating transglutaminases and activating protein 1. J Invest Dermatol 115:731-9
30. Sowden HM, Naseem KM, Tobin DJ (2005) Differential expression of nitric oxide synthases in human scalp epidermal and hair follicle pigmentary units: implications for regulation of melanogenesis. Br J Dermatol 153:301-9
31. Taniuchi S, Kojima T, Hara Mt K, Yamamoto A, Sasai M, Takahashi H et al. (2001) Increased serum nitrate levels in infants with atopic dermatitis. Allergy 56:693-5
32. Watanabe R,Wu K, Paul P, Marks DL, Kobayashi T, Pittelkow MR et al. (1998) Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation. J Biol Chem 273:9651-5
33. Weller R (2003) Nitric oxide: a key mediator in cutaneous physiology. Clin Exp Dermatol 28:511-4
34. Yuspa SH, Hennings H, Tucker RW, Jaken S, Kilkenny AE, Roop DR (1988) Signal transduction for proliferation and differentiation in keratinocytes. Ann N Y Acad Sci 548:191-6